***Background.*** cUTI is a frequent cause of hospitalization and results in considerable morbidity and mortality. While this is well appreciated, scant data are available on the economic burden posed by the various Gram-negative pathogens that cause cUTIs. The objectives of this study were to compare hospital length of stay (LOS) and total hospital costs for patients with cUTI due to different Gram-negative bacteria.

***Methods.*** Retrospective observational study using Premier research database was conducted. Inclusion criteria: (1) age ≥ 18 years, (2) patients with an admission to hospital for \> 2 days between July 2012-June 2013, (3) primary diagnosis of cUTI by ICD-9 codes (590.1, 590.80, 590.8, and 599.0), (4) ICD-9 code for *E. coli* (041.4), *K. pneumoniae* (041.3), or *Pseudomonas* (041.7), and (5) received intravenous antibiotic within 3 days of hospital admission. Demographics, comorbid conditions, and outcomes were compared between pathogens of interests.

***Results.*** During the study period, 20688 hospitalized patients had a primary diagnosis of a cUTI across 487 hospitals and met the above criteria. Patient characteristics and outcomes are presented in the table.

***Conclusion.*** Economic burden associated with complicated urinary tract infection is substantial, especially for patients infected with gram negative infections. In our study, cUTI due to *Pseudomonas* and \> 1 Gram-negative pathogen pose greater economic challenges underscoring the need for new agents to treat these increasingly difficult infections.
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  Patient Characteristics             *E. coli* N=3343    *K.pneumoniae* N=15404    *Pseudomonas* N=1510   *Polymicrobial* N=431
  ----------------------------------- ------------------- ------------------------- ---------------------- -----------------------
  Age, mean(Sd)                       73.5(15.1)          68.4(19.8)                74.1(15.2)             72.0(15.6)
  Female, N (%)                       2455(73.4)          12339 (80.1)              741(49.1)              307(71.2)
  Caucasian                           2500(74.8)          11091(72.0)               1143(75.7)             305(70.8)
  Charlson Comorbidity Score, N (%)                                                                        
    0                                 837(25.0)           5638(36.6)                390(25.8)              101(23.4)
    1                                 817(24.4)           3899(25.3)                322(21.3)              115(26.7)
    2                                 640(19.1)           2412(15.7)                306(20.3)              82(19.0)
    \>=3                              1049(31.4)          3455(22.4)                492(32.6)              133(30.9)
  Patient Outcomes                    *E. coli* N=3343    *K. pneumoniae* N=15404   *Pseudomonas* N=1510   *Polymicrobial* N=431
  LOS, median(IQR)                    4.0(3.0)            3.0(2.0)                  5.0(4.0)               5.0(4.0)
  Total Hospital Cost, median(IQR)    \$ 5751.7(4657.4)   \$ 5320.4(4087.3)         \$ 7002.4(5673.3)      \$ 6974.4(6106.0)
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